We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
351
DELISTED
Air Lease Corp
AL
$4.08M 0.05%
121,815
-10,855
-8% -$411K
IAU icon
352
iShares Gold Trust
IAU
$62.9B
$4.07M 0.05%
118,618
+300
+0.3% +$10.7K
CDMO
353
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4.03M 0.05%
264,013
+78,288
+42% +$1.16M
ONT
354
Onterris Inc
ONT
$759M
$4.02M 0.05%
119,078
+35,353
+42% +$1.48M
ENTG icon
355
Entegris
ENTG
$18.1B
$4M 0.05%
43,412
+2,360
+6% +$256K
DD icon
356
DuPont de Nemours
DD
$18.5B
$3.97M 0.04%
56,713
-1,394
-2% -$114K
DE icon
357
Deere & Co
DE
$160B
$3.95M 0.04%
13,186
-275
-2% -$101K
TPIC
358
DELISTED
TPI Composites
TPIC
$3.94M 0.04%
314,799
+93,698
+42% +$1.23M
MDT icon
359
Medtronic
MDT
$109B
$3.88M 0.04%
43,166
-529
-1% -$53.6K
USB icon
360
US Bancorp
USB
$98.2B
$3.87M 0.04%
84,131
+1,653
+2% +$82.5K
UEIC icon
361
Universal Electronics
UEIC
$57.8M
$3.87M 0.04%
151,245
+5,667
+4% +$159K
LMT icon
362
Lockheed Martin
LMT
$134B
$3.85M 0.04%
8,977
+309
+4% +$136K
GIS icon
363
General Mills
GIS
$19.1B
$3.85M 0.04%
51,043
+36
+0.1% +$2.52K
IMGN
364
DELISTED
Immunogen Inc
IMGN
$3.85M 0.04%
854,646
+10,483
+1% +$45.5K
XNCR icon
365
Xencor
XNCR
$1.5B
$3.83M 0.04%
139,691
+41,230
+42% +$1.02M
IDXX icon
366
Idexx Laboratories
IDXX
$44.1B
$3.73M 0.04%
10,635
-147
-1% -$59.9K
FATE icon
367
Fate Therapeutics
FATE
$286M
$3.72M 0.04%
150,013
+44,513
+42% +$1.23M
VTI icon
368
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$3.69M 0.04%
19,548
-3,953
-17% -$812K
WY icon
369
Weyerhaeuser
WY
$18B
$3.61M 0.04%
109,069
+1,653
+2% +$63K
UFPI icon
370
UFP Industries
UFPI
$4.9B
$3.56M 0.04%
52,162
-10,739
-17% -$809K
SRI icon
371
Stoneridge
SRI
$195M
$3.52M 0.04%
205,340
+13,466
+7% +$256K
KLAC icon
372
KLA
KLAC
$239B
$3.46M 0.04%
108,100
+5,100
+5% +$171K
CHD icon
373
Church & Dwight Co
CHD
$23.4B
$3.45M 0.04%
37,235
VWO icon
374
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.42M 0.04%
82,401
-4,525
-5% -$195K
BDX icon
375
Becton Dickinson
BDX
$45.6B
$3.37M 0.04%
13,699
-607
-4% -$154K

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.